Aker BioMarine is a biotechnology and krill harvesting company that develops, markets and sells krill-based products. The company is an international leader in sustainable harvesting and develops, markets and sells krill-based ingredients and products.
Aker’s ownership agenda
Aker owns 77.8 % of the shares in Aker BioMarine. In its capacity as owner, Aker is encouraging Aker BioMarine to continue leading the way for sustainable fishing with the lowest possible carbon footprint.
Aker believes that Aker BioMarine has the opportunity to establish a strong position in niches driven by global health trends and the demand for omega-3 ingredients. The ambition is to create a larger and more robust company with a focus on good operations and an efficient value chain.
Aker BioMarine produces and distributes a product portfolio of a range of krill-derived products for aquaculture, pet food and human consumption. Krill oil for human consumption is sold under the brand Superba. QRILL Aqua and QRILL High Protein are the company’s nutrient rich feed ingredients for aquaculture, while QRILL Pet is a functional ingredient for pet food.
Building global brands
Aker BioMarine owns two brand companies: Lang Pharma Nutrition Inc. and Epion.
Lang is a mass market private label and corporate brand manufacturer specialized within healthcare products. Lang has 146 products for major US retailers, such as Walmart, Target, and CVS Pharmacy.
Aker BioMarine established Epion to build a strong national brand in mass market retail. In 2020, it launched Aker BioMarine’s omega-3 consumer brand, Kori, to major U.S. retailers.
Sustainability in focus since Day 1
Sustainability has been an integral element of Aker BioMarine’s operations and business model since the company’s inception.
For six years in a row, Aker BioMarine’s krill fishery has received an “A” rating for its well-managed fishery from Sustainable Fisheries Partnerships (SFP). Aker BioMarine has also received its third consecutive certification from the Marine Stewardship Council (MSC) for its sustainable Antarctic krill fishery following an independent assessment. The company was initially certified in 2010, being the first krill company to carry the MSC label.
Aker BioMarine maintains an extensive stakeholder collaboration with authorities, science institutions and environmental NGOs engaged in the Antarctic region specifically, as well as the broader community proposing marine resources as an important component into future foods and nutrients.
Aker BioMarine partnered the establishment of the Antarctic Wildlife Research Fund (AWR) to facilitate and promote Antarctic marine ecosystem research. Aker BioMarine reports on climate risks and opportunities in alignment with the Task Force on Climate-related Financial Disclosures (TCFD) and the Caron Disclosure Project (CDP), and tracks progress against its 2030 carbon reduction target.